SCHEMBL21452791

SCHEMBL21452791

CC(=O)NCCCCNc1ccnc(-c2ccc(C(F)(F)F)c(F)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 4/20 0.43
▸ FAAH O00519 1/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CLK4 Q9HAZ1 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDO2 P48775 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KMO O15229 1/20 0.38
▸ CYP11B2 P19099 3/20 0.37
▸ CYP11B1 P15538 2/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ TRPV4 Q9HBA0 1/20 0.37
▸ SYK P43405 1/20 0.37
▸ MPL P40238 1/20 0.36
▸ GCGR P47871 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452878 0.98 KIF11 (0.43) KIF11FAAHCYP1A2CYP3A4CLK4
SCHEMBL21452945 0.85 KIF11 (0.41) KIF11FAAHCYP1A2CYP3A4CLK4
SCHEMBL21434040 0.85 FAAH (0.43) FAAHCYP3A4TDO2KMOTRPA1
SCHEMBL21434173 0.82 FAAH (0.43) FAAHCYP3A4TDO2KMOTRPA1
SCHEMBL21452790 0.82 FAAH (0.41) KIF11FAAHCYP3A4KMOCYP11B2
SCHEMBL21434049 0.78 FAAH (0.44) FAAHCYP1A2CYP3A4CLK4TSHR
SCHEMBL582158 0.71 KDM4E (0.53) KIF11KMOCYP11B2CYP11B1SYK
SCHEMBL21433993 0.71 FAAH (0.42) FAAHCYP3A4KMOTRPA1TRPV4
SCHEMBL21453072 0.70 FAAH (0.39) KIF11FAAHCYP11B2CYP11B1TRPA1
SCHEMBL21434083 0.70 PDK2 (0.42) FAAHCYP3A4KMOTRPA1TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback